ByteDance Reportedly Poised to Spend Up to 89 Billion in AI Expansion AIRelated Layoffs May Not Guarantee Stock Gains Data Suggests Check Point Software Leverages Buyback Expansion and AI Security Strategy Following Revenue Reset Fresh US Military Strikes Raise Uncertainties for Iran Nuclear Diplomacy AI May Accelerate Discovery of Drugs for Brain Conditions Like MND US Consumer Sentiment Hits Record Low in May as Iran Conflict Fuels Inflation Concerns ACAD Q1 2026 Earnings EPS Misses Estimates as Biotech Faces Profitability Headwinds BWX Technologies Q1 2026 Earnings EPS Surges Past Estimates as Nuclear Backlog Strengthens MU Q1 2026 Earnings Strong EPS Beat Drives 19 Stock Surge LSBK Q3 2025 Earnings EPS of 032 Stands Alone Amid Sparse Disclosure Pathward Financial Inc CASH Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Underlying Strength LCTX Q1 2026 Earnings EPS Miss Weighs on Sentiment as ClinicalStage Biotech Continues Pipeline Progress BrainsWay BWAY Rallies 54 as Strong Volume Lifts Shares Above Key Support Equus Total Return Inc EQS Holds Steady Near Support as Consolidation Persists WaFd Inc WAFD Holds Steady Near Support as Consolidation Continues Rani Therapeutics RANI Tests Key Resistance at 100 After Marginal Gain Sangoma Technologies SANG Climbs 273 as Buyers Push Price Toward Key Resistance at 395 MENA Leaders Advocate for Holistic Housing Policy Beyond Construction at Baku Forum Angel Studios Inc ANGX Q1 2026 Earnings Narrowing Losses Surprisedriven Stock Rally Tempus AI Inc TEM Holds Steady Near Support as Momentum Fades Eagle Materials Q1 2026 Earnings EPS Surges 206 Above Estimates Shares Rally WVVI Q1 2024 Earnings Loss per Share of 022 Reported as Company Navigates Seasonal Challenges OLB Q4 2025 Earnings Narrower Loss Beats Estimates as Stock Rises PROG Holdings Q1 2026 Earnings Massive EPS Beat Drives Investor Caution Despite Strong Performance ELDN Q1 2026 Earnings ClinicalStage Biotech Misses EPS Estimates Amid Ongoing Development Costs DTIL Q1 2026 Earnings EPS Misses Estimates as PreCommercial Biotech Advances Pipeline Movado Group Q1 2026 Earnings Massive EPS Beat Drives Stock Higher